RT Journal Article SR Electronic T1 Leveraging engineered Pseudomonas putida minicells for bioconversion of organic acids into short-chain methyl ketones JF bioRxiv FD Cold Spring Harbor Laboratory SP 2024.01.06.574483 DO 10.1101/2024.01.06.574483 A1 Kozaeva, Ekaterina A1 Nieto-Domínguez, Manuel A1 Tang, Kent Kang Yong A1 Nikel, Pablo Iván YR 2024 UL http://biorxiv.org/content/early/2024/01/06/2024.01.06.574483.abstract AB Methyl ketones, key building-blocks widely used in diverse industrial applications, largely depend on oil-derived chemical methods for their production. Here, we investigated bio-based production alternatives for short-chain ketones, adapting the solvent-tolerant soil bacterium Pseudomonas putida as a host for ketone biosynthesis either by whole-cell biocatalysis or using engineered minicells, chromosome-free bacterial vesicles. Organic acids (acetate, propanoate and butyrate) were selected as the main carbon substrate to drive the biosynthesis of acetone, 2-butanone and 2-pentanone. Pathway optimization identified efficient enzyme variants from Clostridium acetobutylicum and Escherichia coli, which were tested under both constitutive and inducible expression of the cognate genes. By implementing these optimized pathways in P. putida minicells, which can be prepared through a simple 3-step purification protocol, the feedstock was converted into the target short-chain methyl ketones, remaining catalytically functional for >4 months. These results highlight the value of combining morphology and pathway engineering of non-canonical bacterial hosts to establish alternative bioprocesses for toxic chemicals that are difficult to produce by conventional approaches.Competing Interest StatementThe authors have declared no competing interest.